Anti-MU5AC Antibody (Ensituximab)
Catalog No.
F1630
Anti-MU5AC Antibody (Ensituximab)
Featured Products
Ensituximab (NEO-102; NPC-1C) is a targetedChimeric monoclonal IgG1 antibody against MUC5AC variants. Ensituximab shows specificity for colorectal and pancreatic cancer.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
142.82 kDa
Dry ice
1092658-06-4
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
NPC-1C, NEO-101, NEO-102
100 mM Pro 20 mM Arg pH 5.0. No preservative!
E9PGF7
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
MU5AC
Please avoid freeze-thaw cycles.